PSAFT - Overview: Prostate-Specific Antigen (PSA), Total and Free, Serum

Test Catalog

Test Name

Test ID: PSAFT    
Prostate-Specific Antigen (PSA), Total and Free, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

The percentage of measured prostate-specific antigen (PSA) existing in the free form (free:total PSA ratio) is useful in assessing the risk of prostate cancer in patients with borderline or moderately increased total PSA (4.0-10.0 ng/mL) and has been used to help select men who should have follow-up prostate biopsy

Method Name A short description of the method used to perform the test

Electrochemiluminescent Immunoassay (ECLIA)

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

PSA Total and Free, S

Aliases Lists additional common names for a test, as an aid in searching

Free PSA
PSA (Prostate-Specific Antigen)
PSA Free/Total Ratio
PSA Total and Free
PSA Ratio